Effect of autologous blood donation on the central venous pressure, blood loss and blood transfusion during living donor left hepatectomy

Table 1 Characteristics of patients of GI and GII

	GI (n = 35)	GII (n = 49)
Age (yr)	31.1 ± 5.9	33.9 ± 8.7
Weight (kg)	59.1 ± 9.1	56 ± 8.8
Gender (female/male)	24/11	31/18
SGOT (U/L)	17 ± 6.5	46.3 ± 4.7
SGPT (U/L)	15 ± 11.2	20.9 ± 4.4
ALP (U/L)	53.9 ± 21	56.4 ± 15.7
Total bilirubin (mg, %)	0.58 ± 0.22	0.67 ± 0.2
BUN (mg, %)	12.8 ± 3.3	15.8 ± 13.9
Creatinine (mg, %)	0.79 ± 0.7	0.75 ± 0.1
Anesthesia time (h)	10.4 ± 1.5	10. ± 1.1
Blood loss (mL)	63.8 ± 56	67 ± 63
Fluid 1 [mL/(kg·h)]	3.0 ± 2.3	3.4 ± 0.9
Fluid 2 [mL/(kg·h)]	9.4 ± 6.3	10 ± 3.7
Urine 1 [mL/(kg·h)]	1.6 ± 0.7	1.6 ± 0.7
Urine 2 [mL/(kg·h)]	2.0 ± 1.8	1.7 ± 1.3
Preoperative Hb (g/dL)	11.9 ± 1.8a	12.3 ± 1.5
Postoperative d 1 Hb (g/dL)	11.4 ± 1.83a	12.4 ± 1.6
Postoperative d 2 Hb (g/dL)	11.2 ± 2.0a	12.3 ± 1.5
Postoperative d 3 Hb (g/dL)	10.5 ± 1.6a	11.7 ± 1.4
Postoperative d 4 Hb (g/dL)	9.8 ± 0.9a	11.7 ± 1.69
Furosemide (mg)	11.6 ± 5.0	12.2 ± 1.5

1: Before graft procurement, 2: after graft procurement.

^aP < 0.05 vs others. SGOT: serum glutamic oxaloacetic transaminase; SGPT: serum glutamic pyruvic transaminase; ALP: alkaline phosphatase.